New portable MRI could make brain scans safer for kids
NCT ID NCT04629469
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new, portable MRI machine that uses a very low magnetic field on children who already need a brain scan. The goal is to see if this low-field MRI can produce images as good as standard MRI, CT, or ultrasound. Up to 250 children from birth to 22 years old will get an extra scan with the portable device, and the results will be compared to their regular scans. If successful, this technology could make brain imaging easier, safer, and more comfortable for children.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hyperfine low-field MRI device
- What this could lead to
- If it works, this could make brain imaging safer, cheaper, and more accessible for children, especially at the bedside.
- What could go wrong
- This is an early-stage diagnostic study. The low-field MRI may not be as accurate as standard scans, and results are not used for clinical decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONDITIONS REQUIRING A BRAIN MAGNETIC RESONANCE IMAGING, HEAD COMPUTERIZED TOMOGRAPHY, OR HEAD ULTRASOUND are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Mercy Hospital
RECRUITINGKansas City, Missouri, 64108, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.